Hanyuan Zhang

Lucas He, Krinos Li, Hanyuan Zhang et al.

Cerebral small vessel disease (CSVD) markers, specifically enlarged perivascular spaces (EPVS) and lacunae, present a unique challenge in medical image analysis due to their radiological mimicry. Standard segmentation networks struggle with feature interference and extreme class imbalance when handling these divergent targets simultaneously. To address these issues, we propose a morphology-decoupled framework where Zero-Initialized Gated Cross-Task Attention exploits dense EPVS context to guide sparse lacune detection. Furthermore, biological and topological consistency are enforced via a mixed-supervision strategy integrating Mutual Exclusion and Centerline Dice losses. Finally, we introduce an Anatomically-Informed Inference Calibration mechanism to dynamically suppress false positives based on tissue semantics. Extensive 5-folds cross-validation on the VALDO 2021 dataset (N=40) demonstrates state-of-the-art performance, notably surpassing task winners in lacunae detection precision (71.1%, p=0.01) and F1-score (62.6%, p=0.03). Furthermore, evaluation on the external EPAD cohort (N=1762) confirms the model's robustness for large-scale population studies. Code will be released upon acceptance.

Lucas He, Hanyuan Zhang, Krinos Li et al.

Cerebral microbleeds (CMBs) are MRI markers of small vessel disease and the microbleed component of amyloid related imaging abnormalities (ARIA-H), but their small size, sparsity, and similarity to vessels, calcification-like foci, and artefacts make automated detection difficult. We propose CenSynCMB, a centre-guided and mimic-aware framework combining a 3D Attention U-Net, auxiliary centre-map supervision, false-negative-driven reweighting, and fold-wise physics-guided synthesis of positive CMBs and labelled hard negatives. Synthetic data expose the detector to compact lesions and common mimics without validation or test leakage. On VALDO Task 2, CenSynCMB achieved the best local-comparison lesion-level F1 (74.3%, p = 0.020); on external AIBL SWI, it achieved the highest local-comparison recall (88.5%, p = 0.0058) and F1 (65.0%, p = 0.0016). Together, these results support scalable CMB candidate extraction in large, unlabelled MRI cohorts, while highlighting cohort-specific calibration as the next step toward reliable burden estimation.